Stemtech Corporation
STEK · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.41 | 0.04 | -0.00 | 0.05 |
| FCF Yield | 1.28% | 1.95% | -18.06% | -18.55% |
| EV / EBITDA | -18.96 | -44.16 | -6.65 | 57.74 |
| Quality | ||||
| ROIC | 0.02% | 13.02% | 79.36% | -2.35% |
| Gross Margin | 80.08% | 79.09% | 82.98% | 79.55% |
| Cash Conversion Ratio | -0.03 | -0.25 | 0.49 | 2.57 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.00% | -3.76% | 0.02% | 3.49% |
| Free Cash Flow Growth | -66.68% | 110.55% | 30.32% | -141.28% |
| Safety | ||||
| Net Debt / EBITDA | -9.84 | -22.15 | -3.29 | 22.70 |
| Interest Coverage | 0.42 | -3.78 | -4.91 | 0.06 |
| Efficiency | ||||
| Inventory Turnover | 0.72 | 0.53 | 0.78 | 1.36 |
| Cash Conversion Cycle | 158.82 | -3,010.36 | -2,830.17 | -1,429.41 |